Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189Phase 3Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozagrel in dry eye syndrome (DED), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
ozagrel
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02503189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503189.